New study tracks how cancer surgery affects Kids' walking
NCT ID NCT07502885
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how well children walk after having surgery for bone or soft tissue cancer in their legs. Researchers will use 3D cameras, muscle sensors, and wearable devices to measure movement in 300 children, comparing them to healthy kids of the same age. The goal is to understand what causes walking problems and how they change over time, so doctors can find better ways to help.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and predict walking problems in children after cancer surgery, leading to improved rehabilitation strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve outcomes for participants, and results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Jan 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study includes children, teens, and young adults ages 5-20 who receive care at St. Jude and need lower limb orthopedic surgery for bone sarcoma, soft tissue sarcoma, or steroid induced avascular necrosis. These participants will complete walking and movement assessments before surgery and again at several timepoints afterward. The study will include healthy volunteers ages 5-20, mainly friends or siblings of patients, who do not have conditions that affect walking. Healthy participants complete a single visit to provide comparison data. In total, the study will include 150 pediatric cancer patients and 150 healthy controls to help researchers better understand walking patterns and recovery after surgery.
- Ages
-
5 to 20 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria Cases: * Participant requiring orthopedic surgery due to a diagnosis of lower limb bone sarcoma, soft tissue sarcoma, or steroid-induced avascular necrosis (Appendix III) and will receive further additional treatment and/or follow-up care at St. Jude. * Participant is between the ages of ≥5 and ≤20 years old at the time of enrollment. Controls: * Participant is between the ages of ≥5 and ≤20 years old at the time of enrollment. * Participant (or their parent/legal guardian) considers themself healthy for their age. * Participant (or their parent/legal guardian) reports being able to participate in normal daily activities of life with respect to their age. Exclusion Criteria Cases: * Individuals with pre-existing genetic/congenital disorders affecting gait will be excluded e.g., cerebral palsy. * Individuals who are unable to follow age-appropriate instructions during the gait assessment. * Inability or unwillingness of research participant or legal guardian/representative to give written informed consent. * Individuals diagnosed with radiation-induced avascular necrosis. Controls: * Individuals who are unable to follow age-appropriate instructions during the gait assessment. * Individuals who self-report health conditions affecting gait and mobility. * Individuals who have the following conditions: diabetes mellitus due to impaired circulation, sensation and strength, malignant cancers, demyelinating inflammatory and degenerative neurological conditions, pregnancy, obesity (BMI \>40 kg/m2), severe cardiac or pulmonary disease affecting performance of daily activities, history of major surgery affecting gait and mobility, infections or inflammatory arthropathies, severe mobility impairment necessitating dependence on mobility aids for all ambulation. * Individual or legal guardian/representative is unable or unwilling to give written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gait disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
- Cancer-Killing virus injected directly into tumors shows promise in Mid-Stage trial
- New drug combo shows promise for rare sarcoma
- New chemo combo shows promise for rare sarcoma
- New drug cocktail shows promise for rare sarcomas
- Scientists launch international registry to crack the code of ultra-rare cancer EHE